Skip to main content
Premium Trial:

Request an Annual Quote

Betsy Humphreys, W. Ann Reynolds, Gary Taylor, Lester Crawford, and David Danley

Premium

Betsy Humphreys has been promoted to deputy director of the National Institutes of Health’s National Library of Medicine, the parent institute for the National Center for Biotechnology Information. She has been NLM associate director for library operations since 1999, after joining the NLM in 1973. She holds a bachelor’s degree in history from Smith College and a master’s degree in library science from the University of Maryland.


Invitrogen said this week that W. Ann Reynolds has been appointed to the company’s board of directors.

The appointment increases the number of Invitrogen board members to 10 from nine.

Reynolds served as president of the University of Alabama at Birmingham between 1997 and 2002. Prior to this, she was chancellor of the City University of New York, and before that chancellor of the California State University system.

Reynolds holds a PhD and a masters degree in zoology from the University of Iowa, and a bachelors degree in biology from Emporia State University.


Benitec said this week that Gary Taylor has resigned as a director of the company. He will remain on as company secretary.

Taylor founded and is principal of Bentley Barton Chartered Accountants, according to Benitec. He is a director of Synergene Holdings and is non-executive chairman of Integrated Investment Group. He was been involved with Benitec since 1997.


Lester Crawford will be nominated as permanent head of the Food and Drug Administration, President Bush said on Monday. He is currently the agency’s acting commissioner.

Crawford, who was already considered for the position once before in 2001 but became deputy commissioner and acting commissioner instead, replaces Mark McClellan, who left the FDA in March of 2004 to become the head of the Center for Medicare and Medicaid Services.

Crawford holds doctorate degrees in veterinary medicine from Auburn University and in pharmacology from the University of Georgia.


David Danley has joined the board of directors of therapeutic antibody firm Hematech, the Sioux Falls, SD-based company said last week.

Danley is the director for homeland security and defense programs at CombiMatrix. Prior to that, he was project manager of the chemical biological medical systems and joint vaccine acquisition program for the Department of Defense.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.